Aarti Pharmalabs Limited has informed the Exchange regarding a press release dated April 29, 2025, titled "Aarti Pharmalabs Earns EcoVadis Gold Rating, Among Top 5% Globally for Sustainability".
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs Limited has announced that it has received an EcoVadis Gold Rating, placing it among the top 5% of companies worldwide assessed by EcoVadis for sustainability performance. EcoVadis is a globally recognized platform that evaluates companies on environmental, social, and ethical practices across four key areas: environment, labor and human rights, ethics, and sustainable procurement. The rating was disclosed through a press release dated April 29, 2025.
This is a positive ESG milestone that strengthens the company's sustainability credentials and may attract interest from ESG-focused funds and long-term investors, though it has no immediate direct impact on earnings or stock price.